New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. [electronic resource]
Producer: 20050209Description: 1201-3 p. digitalISSN:- 0006-4971
- Adolescent
- Age Factors
- Antineoplastic Agents -- administration & dosage
- Bone Marrow Transplantation -- methods
- Chelating Agents -- administration & dosage
- Child
- Child, Preschool
- Clinical Protocols
- Deferoxamine -- administration & dosage
- Erythrocyte Transfusion
- Female
- Growth Substances -- administration & dosage
- Hematopoiesis -- drug effects
- Humans
- Immunosuppressive Agents -- administration & dosage
- Male
- Prognosis
- Recurrence
- Risk Assessment
- Survival Analysis
- Thalassemia -- mortality
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.